Genistein: A boon for mitigating ischemic stroke

Current Topics in Medicinal Chemistry

Volumn 15, Issue 17, 2015, Pages 1714-1721

  Nabavi, Seyed Fazel ^a   Daglia, Maria ^b   Tundis, Rosa ^c   Loizzo, Monica Rosa ^c   Sobarzo Sánchez, Eduardo ^d,e   Orhan, Ilkay Erdogan ^f   Nabavi, Seyed Mohammad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^f GAZI UNIVERSITY   (Turkey)

Author keywords

Genistein; Isoflavone; Oxidative stress; Signal transduction

Indexed keywords

GENISTEIN; ISOFLAVONE; PROTEIN KINASE INHIBITOR;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CHEMICAL STRUCTURE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; STROKE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN ISCHEMIA; GENISTEIN; HUMANS; MOLECULAR STRUCTURE; PROTEIN KINASE INHIBITORS; STROKE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84931838009     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150427122709     Document Type: Article

References (107)

1. Lim, S. S.; Gaziano, T.A.; Gakidou, E.; Reddy, K.S.; Farzadfar, F.; Lozano, R.; Rodgers, A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet, 2007, 370(9604), 2054-2062.
2. van der Worp, H.B.; van Gijn, J. Acute ischemic stroke. N. Engl. J. Med., 2007, 357(6), 572-579.
3. Muller-Nordhorn, J.; Nolte, C.H.; Rossnagel, K.; Jungehulsing, G.J.; Reich, A.; Roll, S., Villringer, A.; Willich, S.N. Knowledge about risk factors for stroke a population-based survey with 28 090 participants. Stroke, 2006, 37(4), 946-950.
4. Markus, H.S.; Khan, U.; Birns, J.; Evans, A.; Kalra, L.; Rudd, A.G.; Wolfe, C.D.A.; Jerrard-Dunne, P. Differences in stroke subtypes between black and white patients with stroke the south London ethnicity and stroke study. Circulation, 2007, 116(19), 2157- 2164.
5. Truelsen, T.; Piechowski-Joźwiak, B.; Bonita, R.; Mathers, C.; Bogousslavsky, J.; Boysen, G. Stroke incidence and prevalence in Europe: a review of available data. Eur. J. Neurol., 2006, 13(6), 581-598.
6. Wechsler, L.R. Intravenous thrombolytic therapy for acute ischemic stroke. N. Engl. J. Med., 2011, 364(22), 2138-2146.
7. European Stroke Organization (ESO) Executive Committee, & ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis., 2008, 25(5), 457-507.
8. Martino, R.; Foley, N.; Bhogal, S.; Diamant, N.; Speechley, M.; Teasell, R. Dysphagia after stroke incidence, diagnosis, and pulmonary complications. Stroke 2005, 36(12), 2756-2763.
9. Sagen, U.; Finset, A.; Moum, T.; Morland, T.; Vik, T.G.; Nagy, T.; Dammen, T. Early detection of patients at risk for anxiety, depression and apathy after stroke. Gen. Hosp. Psychiatry, 2010, 32(1), 80-85.
10. Nabavi, S.F.; Turner, A.; Dean, O.M.; Sureda, A.; Nabavi, S.M. Post-Stroke Depression therapy: where are we now? Curr. Neurovasc. Res., 2014, DOI: 10.2174/1567202611666140522- 123504
11. Schmahmann. J.D.; Rosene, D.L.; Pandya, D.N. Ataxia after pontine stroke: insights from pontocerebellar fibers in monkey. Ann. Neurol., 2004, 55(4), 585-589.
12. Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Adams, R.J.; Berry, J.D.; Brown, T.M.; Carnethon, M.R.; Dai, S.; de Simone, G.; Ford, E.S.; Fox, C.S.; Fullerton, H.J.; Gillespie, C.; Greenlund, K.J.; Hailpern, S.M.; Heit, J.A.; Ho, P.M.; Howard, V.J.; Kissela, B.M.; Kittner, S.J.; Lackland, D.T.; Lichtman, J.H.; Lisabeth, L.D.; Makuc, D.M.; Marcus, G.M.; Marelli, A.; Matchar, D.B.; McDermott, M.M.; Meigs, J.B.; Moy, C.S.; Mozaffarian, D.; Mussolino, M.E.; Nichol, G.; Paynter, N.P.; Rosamond, W.D.; Sorlie, P.D.; Stafford, R.S.; Turan, T.N.; Turner, M.B.; Wong, N.D.; Wylie-Rosett, J. Heart disease and stroke statistics-2011 update a report from the American Heart Association. Circulation, 2011, 123(4), e18-209.
13. Rothwell, P.M.; Coull, A.J.; Giles, M.F.; Howard, S.C.; Silver, L.E.; Bull, L.M.; Gutnikov, S.A.; Edwards, P.; Mant, D.; Sackley, C.M.; Farmer, A.; Sandercock, P.A.; Dennis, M.S.; Warlow, C.P.; Bamford, J.M.; Anslow, P. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet, 2004, 363(9425): 1925-1933.
14. Puskas, J.D.; Winston, A.D.; Wright, C.E.; Gott, J.P.; Brown III, W.M.; Craver, J.M.; Jones, E.L.; Guyton, R.A.; Weintraub, W.S. Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann. Thorac. Surg., 2000, 69(4), 1053-1056.
15. Wang, Y.; Lim, L.L.Y.; Levi, C.; Heller, R.F.; Fisher, J. Influence of admission body temperature on stroke mortality. Stroke, 2000, 31(2), 404-409.
16. Candelario-Jalil, E.; Mhadu, N.H.; Al-Dalain, S.M.; Martínez, G.; Leon, O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res., 2001, 41(3), 233-241.
17. Broughton, B.R.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke, 2009, 40(5), e331-e339.
18. Feustel, P.J.; Jin, Y.; Kimelberg, H.K. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke, 2004, 35(5), 1164-1168.
19. Leker, R.R.; Shohami, E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Rev., 2002, 39(1), 55-73.
20. Niizuma, K.; Endo, H.; Chan, P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem., 2009, 109(s1), 133-138.
21. Ridder, D.A.; Schwaninger, M. NF-κB signaling in cerebral ischemia. Neuroscience, 2009, 158(3), 995-1006.
22. Sun, X.C.; Li, W.B.; Li, Q.J.; Zhang, M.; Xian, X.H.; Qi, J.; Jin, R.L.; Li, S.Q. Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK. Brain Res., 2006, 1084(1), 165- 174.
23. Rosell, A.; Ortega-Aznar, A.; Alvarez-Sabin, J.; Fernandez- Cadenas, I.; Ribo, M.; Molina, C.A.; Lo, E.H.; Montaner, J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke, 2006, 37(6), 1399-1406.
24. Collino, M.; Aragno, M.; Mastrocola, R.; Benetti, E.; Gallicchio, M.; Dianzani, C.; Danni, O.; Thiemermann, C.; Fantozzi, R. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist WY14643. Free Radic. Biol. Med., 2006, 41(4), 579-589.
25. Nabavi, S.F.; Russo, G.L.; Daglia, M.; Nabavi, S.M. Role of quercetin as an alternative for obesity treatment: You are what you eat! Food Chem., 2015, 179, 305-310.
26. Duthie, G.; Crozier, A. Plant-derived phenolic antioxidants. Curr. Opin. Lipidol., 2000, 11(1), 43-7.
27. Nabavi, S.M.; Marchese, A.; Izadi, M.; Curti, V.; Daglia, M.; Nabavi, S.F. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food Chem., 2015, 173, 339-347.
28. Nabavi, S.F.; Nabavi, S.M.; Setzer, W.N.; Nabavi, S.A.; Nabavi, S.A.; Ebrahimzadeh, M.A. Antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits. Fruits, 2013, 68(03), 185-193.
29. Nabavi, S.F.; Nabavi, S.M.; Ebrahimzadeh, M.A.; Jafari, N.; Yazdanpanah, S. Biological activities of freshwater algae, Spirogyra singularis Nordstedt. J. Aquat. Food Prod. Technol., 2013, 22(1), 58-65.
30. Nabavi, S.F.; Nabavi, S.M.; Ebrahimzadeh, M.A.; Eslami, B.; Jafari, N. In vitro antioxidant and antihemolytic activities of hydroalcoholic extracts of Allium scabriscapum Boiss. & Ky. aerial parts and bulbs. Int. J. Food Prop., 2013, 16(4), 713-722.
31. Luo, X.D.; Basile, M.J.; Kennelly, E.J. Polyphenolic antioxidants from the fruits of Chrysophyllum cainito L.(star apple). J. Agric. Food Chem., 2002, 50(6), 1379-1382.
32. Alinezhad, H.; Azimi, R.; Zare, M.; Ebrahimzadeh, M.A.; Eslami, S.; Nabavi, S.F.; Nabavi, S.M. Antioxidant and antihemolytic activities of ethanolic extract of flowers, leaves, and stems of Hyssopus officinalis L. var. angustifolius. Int. J. Food Prop., 2013, 16(5), 1169-1178.
33. Russo, G.L. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol., 2007, 74(4), 533-544.
34. Daglia, M. Polyphenols as antimicrobial agents. Curr. Opin. Biotechnol., 2012, 23(2), 174-181.
35. Nabavi, S.F.; Nabavi, S.M.; Moghaddam, A.H.; Naqinezhad, A.; Bigdellou, R.; Mohammadzadeh, S. Protective effects of Allium paradoxum against gentamicin-induced nephrotoxicity in mice. Food Funct., 2012, 3(1), 28-29.
36. Leopoldini, M.; Russo, N.; Toscano, M. The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem., 2011, 125(2), 288-306.
37. Nabavi, S.F.; Daglia, M.; Moghaddam, A.H.; Habtemariam, S.; Nabavi, S.M. Curcumin and liver disease: from chemistry to medicine. Compr. Rev. Food Sci. Food Safe., 2014, 13(1), 62-77.
38. Obrenovich, M.E.; Nair, N.G.; Beyaz, A.; Aliev, G.; Reddy, V.P. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res., 2010, 13(6), 631-643.
39. Nabavi, S.F.; Nabavi, S.M.; Habtemariam, S.; Moghaddam, A.H.; Sureda, A.; Jafari, M.; Latifi, A.M. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride- induced oxidative stress. Ind. Crops Prod., 2013, 44, 50-55.
40. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev., 2009, 2(5), 270-278.
41. Nabavi, S.F.; Nabavi, S.M.; Mirzaei, M.; Moghaddam, A.H. Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart. Food Funct., 2012, 3(4), 437-441.
42. Hardcastle, A.C.; Aucott, L.; Reid, D.M.; Macdonald, H.M. Associations between dietary flavonoid intakes and bone health in a Scottish population. J. Bone Miner. Res., 2011, 26(5), 941-947.
43. McCullough, M.L.; Peterson, J.J.; Patel, R.; Jacques, P.F.; Shah, R.; Dwyer, J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr., 2012, 95(2), 454-64.
44. Nabavi, S.M.; Nabavi, S.F.; Eslami, S.; Moghaddam, A.H. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem., 2012, 132(2), 931-935.
45. Xiao, Z.P.; Peng, Z.Y.; Peng, M.J.; Yan, W.B.; Ouyang, Y.Z.; Zhu, H.L. Flavonoids health benefits and their molecular mechanism. Mini Rev. Med. Chem., 2011, 11(2), 169-177.
46. Perez-Gregorio, M.R.; Regueiro, J.; Simal-Gandara, J.; Rodrigues, A.S.; Almeida, D.P.F. Increasing the added-value of onions as a source of antioxidant flavonoids: A critical review. Crit. Rev. Food Sci. Nutr., 2014, 54(8), 1050-1062.
47. Ververidis, F.; Trantas, E.; Douglas, C.; Vollmer, G.; Kretzschmar, G.; Panopoulos, N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol. J., 2007, 2(10), 1214-1234.
48. Dixon, R.A.; Ferreira, D. Genistein. Phytochemistry, 2002, 60(3), 205-211.
49. Wang, H.; Murphy, P.A. Isoflavone composition of American and Japanese soybeans in Iowa (effects of variety, crop year and location). J. Agric. Food Chem., 1994, 42, 1674-1677.
50. Mantovani, D.; Cardozo, F.L.; Santos, L.C.; De Souza, V.L.; Watanabe, C.S. Chromatographic quantification of isoflavone content from soy derivates using HPLC technique. J. Chromatogr. Sci., 2009, 47, 766-769.
51. Toro-Funes, N.; Odriozola-Serrano, I.; Bosch-Fuste, J.; Latorre- Moratalla, M.L.; Veciana-Nogues, M.T.; Izquierdo-Pulido, M.; Vidal-Carou, M.C. Fast simultaneous determination of free and conjugated isoflavones in soy milk by UHPLC-UV. Food Chem., 2012, 135, 2832-2838.
52. Klejdus, B.; Vacek, J.; Lojkova, L.; Benesova, L.; Kuban, V. Ultrahigh- pressure liquid chromatography of isoflavones and phenolic acids on different stationary phases. J. Chromatogr. A, 2008, 1195, 52-59.
53. Espinosa-Alonso, L.G.; Lygin, A.; Widholm, J.M.; Valverde, M.E.; Paredes-Lopez, O. Polyphenols in wild and weedy Mexican common beans (Phaseolus vulgaris L.). J. Agric. Food Chem., 2006, 54, 4436-4444.
54. Urpi-Sarda, M.; Morand, C.; Besson, C.; Kraft, G.; Viala, D.; Scalbert, A.; Besle, J.; Manach, C. Tissue distribution of isoflavones in ewes after consumption of red clover silage. Arch. Biochem. Biophys., 2008, 476, 205-210.
55. Yu, O.; McGonigle, B. Metabolic engineering of isoflavone biosynthesis. Adv. Agronomy, 2005, 86, 147-190.
56. Cassidy, A.; Bingham, S.; Setchell, K. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br. J. Nutr., 1995, 74, 587-601
57. Matthies, A.; Clavel, T.; Gutschow, M.; Engst, W.; Haller, D.; Blaut, M.; Braune, A. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl. Environ. Microbiol., 2008, 74(15), 4847-4852.
58. Xu, X.; Wang, H.J.; Murphy, P.A.; Hendrich, S. Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women. J. Nutr., 2000, 130(4), 798-801.
59. Suthar, A.C.; Banavalikar, M.M.; Biyani, M.K. Pharmacological activities of genistein, an isoflavone from soy (Glycine max): Part II-Anti-cholesterol activity, effects on osteoporosis & menopausal symptoms. Ind. J. Exp. Biol., 2001, 39(6), 520-525.
60. Setchell, K.D.; Cassidy, A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr., 1999, 129(3), 758S-767S.
61. Lamartiniere, C.A.; Cotroneo, M.S.; Fritz, W.A.; Wang, J.; Mentor- Marcel, R.; Elgavish, A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr., 2002, 132(3), 552S-558S.
62. Polkowski, K.; Mazurek, A.P. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol. Pharm., 2000, 57(2), 135-155.
63. Altavilla, D.; Crisafulli, A.; Marini, H.; Esposito, M.; D'Anna, R.; Corrado, F.; Bitto, A.; Squadrito, F. Cardiovascular effects of the phytoestrogen genistein. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2004, 2(2), 179-186.
64. Maggiolini, M.; Vivacqua, A.; Fasanella, G.; Recchia, A.G.; Sisci, D.; Pezzi, V.; Montanaro, D.; Musti, A.M.; Picard, D.; Ando, S. The G protein-coupled receptor GPR30 mediates c-fos upregulation by 17β-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem., 2004, 279(26), 27008-16.
65. Shon, Y.; Park, S.; Nam, K. Effective chemopreventive activity of genistein against human breast cancer cells. J. Biochem. Mol. Biol., 2006, 39(4), 448-451
66. Morabito, N.; Crisafulli, A.; Vergara, C.; Gaudio, A.; Lasco, A.; Frisina, N.; D'Anna, R.; Corrado, F.; Pizzoleo, M.A.; Cincotta, M.; Altavilla, D.; Ientile, R.; Squadrito, F. Effects of genistein and hormone-replacement therapy on bone loss in early postmeno pausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res., 2002, 17(10), 1904-1912.
67. Shimada, H.; Eto, M.; Ohtaguro, M.; Ohtsubo, M.; Mizukami, Y.; Ide, T.; Imamura, Y. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein. J. Biochem. Mol. Toxicol., 2010, 24(4), 230-234.
68. Magee, P.J.; Rowland, I. Soy products in the management of breast cancer. Curr. Opin. Clin. Nutr. Metab. Care, 2012, 15(6), 586-591.
69. Ming, L.G.; Chen, K.M.; Xian, C.J. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J. Cell. Physiol., 2013, 228(3), 513-521.
70. Suzuki, K.; Koike, H.; Matsui, H.; Ono, Y.; Hasumi, M.; Nakazato, H.; Okugi, H.; Sekine, Y.; Oki, K.; Ito, K.; Yamamoto, T.; Fukabori, Y.; Kurokawa, K.; Yamanaka, H. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int. J. Cancer, 2002, 99(6), 846-852.
71. Markovits, J.; Linassier, C.; Fosse, P.; Couprie, J.; Pierre, J.; Jacquemin- Sablon, A.; Saucier, J-M.; Le Pecq, J-B.; Larsen, A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 1989, 49(18), 5111- 5117.
72. Khoshyomn, S.; Nathan, D.; Manske, G.C.; Osler, T.M.; Penar, P.L. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells. J. Neuro-Oncol., 2002, 57(3), 193-200.
73. Han, L.; Zhang, H.W.; Zhou, W.P.; Chen, G.M.; Guo, K.J. The effects of genistein on transforming growth factor-β1-induced invasion and metastasis in human pancreatic cancer cell line Panc-1 in vitro. Chin. Med. J., 2012, 125(11), 2032-2040.
74. Atteritano, M.; Marini, H.; Minutoli, L.; Polito, F.; Bitto, A.; Altavilla, D.; Mazzaferro, S.; D'Anna, R.; Cannata, M. L.; Gaudio, A.; Frisina, A.; Frisina, N.; Corrado, F.; Cancellieri, F.; Lubrano, C.; Bonaiuto, M.; Adamo, E.B.; Squadrito, F. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, doubleblind, placebo-controlled study. J. Clin. Endocrinol. Metab., 2007, 92(8), 3068-3075.
75. Tikkanen, M.J.; Adlercreutz, H. Dietary soy-derived isoflavone phytoestrogens: could they have a role in coronary heart disease prevention? Biochem. Pharmacol., 2000, 60(1),1-5.
76. Si, H.; Liu, D. Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J. Nutr., 2008, 138(2), 297-304.
77. Si, H.; Liu, D. Phytochemical genistein in the regulation of vascular function: new insights. Curr. Med. Chem., 2007, 14(24), 2581- 2589.
78. Wei, H.; Bowen, R.; Cai, Q.; Barnes, S.; Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Exp. Biol. Med., 1995, 208(1), 124-130.
79. Lee, J.S. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci., 2006, 79(16), 1578-1584.
80. Zhang, T.; Wang, F.; Xu, H.X.; Yi, L.; Qin, Y.; Chang, H.; Mi, MT.; Zhang, Q.Y. Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Brit. J. Nutr., 2013, 109(02), 223-235.
81. Wang, R.; Tu, J.; Zhang, Q.; Zhang, X.; Zhu, Y.; Ma, W.; Cheng, C.; Brann, D.W.; Yang, F. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus, 2013, 23(7), 634-647.
82. Li, Y.S.; Wu, L.P.; Li, K.B.; Liu, Y.P.; Xiang, R.; Zhang, S.B.; Zhu, L.Y.; Zhang, L.Y. Involvement of nuclear factor κB (NF-κB) in the downregulation of cyclo-oxygenase-2 (COX-2) by genistein in gastric cancer cells. J. Int. Med. Res., 2011, 39(6), 2141-2150.
83. Valachovicova, T.; Slivova, V.; Bergman, H.; Shuherk, J.; Sliva, D. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-tB/AP-1-dependent and-independent pathways. Int. J. Oncol., 2004, 25(5), 1389-1396.
84. Wang, S.D.; Chen, B.C.; Kao, S.T.; Liu, C.J.; Yeh, C.C. Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement. Altern. Med., 2014, 14(1), 26.
85. Yu, J.Y.; Lee, J.J.; Lim, Y.; Kim, T.J.; Jin, Y. R.; Sheen, Y.Y.; Yun, Y.P. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J. Pharmacol. Sci., 2008, 107(1), 90-98.
86. Gong, L.; Li, Y.; Nedeljkovic-Kurepa, A.; Sarkar, F.H. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003, 22(30), 4702-4709.
87. Liu Z, Sall A, Yang D. MicroRNA: an emerging therapeutic target and intervention tool. Int. J. Mol. Sci., 2008, 9(6), 978-999.
88. Erson AE, Petty EM. MicroRNAs in development and disease. Clin. Genetics, 2008, 74(4), 296-306.
89. Curti, V.; Capelli, E.; Boschi, F.; Nabavi, S.F.; Bongiorno, A.I.; Habtemariam, S.; Nabavi, S.M.; Daglia, M. Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Mol. Nutr. Food Res., 2014, Doi:10.1002/mnfr.201400007
90. Parker, L.P.; Taylor, D.D.; Kesterson, J.; Metzinger, D.S.; Gercel- Taylor, C. Modulation of microRNA associated with ovarian cancer cells by genistein. Eur. J. Gynaecol. Oncol., 2008, 30(6), 616- 621.
91. Hirata, H.; Ueno, K.; Nakajima, K.; Tabatabai, Z.L.; Hinoda, Y.; Ishii, N.; Dahiya, R. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Brit. J. Cancer, 2013, 108(10), 2070-2078.
92. Sun, Q.; Cong, R.; Yan, H.; Gu, H.; Zeng, Y.; Liu, N.; Chen, J.; Wang, B. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol. Rep., 2009, 22(3), 563-567.
93. Ma, J.; Cheng, L.; Liu, H.; Zhang, J.; Shi, Y.; Zeng, F.; Miele, L.; Sarkar, F.H.; Xia, J.; Wang, Z. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr. Drug Targets, 2013, 14(10), 1150-1156.
94. Chiyomaru, T.; Yamamura, S.; Fukuhara, S.; Hidaka, H.; Majid, S.; Saini, S.; Arora, S.; Deng, G.; Shahryari, V.; Chang, I.; Tanaka, Y.; Tabatabai, Z.L.; Enokida, H.; Seki, N.; Nakagawa, M.; Dahiya, R. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PloS one, 2013, 8(3), e58929.
95. Lazarevic, B.; Boezelijn, G.; Diep, L.M.; Kvernrod, K.; Ogren, O.; Ramberg, H.; Moen, A.; Wessel, N.; Berg, R.E.; Egge-Jacobsen, W.; Hammarstrom, C.; Svindland, A.; Kucuk, O.; Saatcioglu, F.; Tasken, K.A.; Karlsen, S.J. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, doubleblind Phase 2 clinical trial. Nutr. Cancer, 2011, 63(6), 889-898.
96. Liang, H.W.; Qiu, S.F.; Shen, J.; Sun, L.N.; Wang, J.Y.; Bruce, I.C.; Xia, Q. Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci. Lett., 2008, 438(1), 116-120.
97. Linford, N.J.; Yang, Y.; Cook, D.G.; Dorsa, D.M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Therap., 2001, 299(1), 67-75.
98. Kruk, I.; Aboul-Enein, H.Y.; Michalska, T.; Lichszteld, K.; Kładna, A. Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein. Luminescence, 2005, 20(2), 81-89.
99. Cortina, B.; Torregrosa, G.; Castello-Ruiz, M.; Burguete, M.C.; Moscardo, A.; Latorre, A, Salom, J.B.; Valles, J.; Santos, M.T.; Alborch, E. Improvement of the circulatory function partially accounts for the neuroprotective action of the phytoestrogen genistein in experimental ischemic stroke. Eur. J. pharmacol., 2013, 708(1), 88-94.
100. Schreihofer, D.A.; Redmond, L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience, 2009, 158(2), 602-609.
101. Nakamura, Y.; Yogosawa, S.; Izutani, Y.; Watanabe, H.; Otsuji, E.; Sakai, T. A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol. Cancer, 2009, 8, 100.
102. Wang, S.; Wei, H.; Cai, M.; Lu, Y.; Hou, W.; Yang, Q.; Dong, H.; Xiong, L. Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of ERK activity in ovariectomized mice. Int. J. Biol. Sci., 2014, 10(4), 457-465.
103. Banecka-Majkutewicz, Z.; Sawula, W.; Kadzinski, L.; Węgrzyn, A.; Banecki, B. Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke-pathogenic and therapeutic implications. Acta Biochim. Pol., 2012, 59(4), 495-499.
104. Yu, J.Y.; Lee, J.J.; Lim, Y.; Kim, T.J.; Jin, Y.R.; Sheen, Y.Y.; Yun, Y. P. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J. Pharmacol. Sci., 2008, 107(1), 90-98.
105. Qian, Y.; Guan, T.; Huang, M.; Cao, L.; Li, Y.; Cheng, H.; Jin, H.; Yu, D. Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-κB activation in a cerebral ischemia mouse model. Neurochem. Int., 2012, 60(8), 759-767.
106. Xu, J.W.; Ikeda, K.; Yamori, Y. Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II-type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertens. Res., 2004, 27(9), 675-683.
107. Linford, N.J.; Dorsa, D.M. 17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids, 2002, 67(13), 1029-1040.